Journey Competitors
| DERM Stock | USD 7.73 0.02 0.26% |
Journey Medical vs Nyxoah Correlation
Weak diversification
The correlation between Journey Medical Corp and NYXH is 0.31 (i.e., Weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Journey Medical Corp and NYXH in the same portfolio, assuming nothing else is changed.
Moving against Journey Stock
As of the 17th of February 2026, Return On Tangible Assets is likely to drop to -0.29. In addition to that, Return On Capital Employed is likely to drop to -0.29. At this time, Journey Medical's Other Current Assets are very stable compared to the past year. As of the 17th of February 2026, Intangible Assets is likely to grow to about 38.5 M, while Non Current Assets Total are likely to drop about 17.2 M.Journey Medical Competition Correlation Matrix
Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Journey Medical and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of Journey and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Journey Medical Corp does not affect the price movement of the other competitor.
High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Journey Stock performing well and Journey Medical Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Journey Medical's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| OGI | 3.01 | (0.32) | 0.00 | (0.56) | 0.00 | 7.01 | 29.65 | |||
| RNAC | 3.39 | (0.10) | 0.00 | (0.08) | 0.00 | 7.26 | 28.90 | |||
| SXTC | 9.85 | (3.81) | 0.00 | (17.56) | 0.00 | 18.34 | 106.44 | |||
| FENC | 2.11 | 0.15 | 0.04 | 0.54 | 2.67 | 4.86 | 17.84 | |||
| HSDT | 5.70 | (1.23) | 0.00 | (0.52) | 0.00 | 13.03 | 29.52 | |||
| OBIO | 3.92 | (0.02) | 0.02 | 0.05 | 4.22 | 10.17 | 22.05 | |||
| IVA | 3.34 | 0.81 | 0.21 | 1.72 | 3.26 | 9.41 | 20.30 | |||
| OSUR | 2.35 | 0.16 | 0.07 | 0.14 | 2.83 | 5.98 | 13.45 | |||
| MDWD | 1.87 | (0.07) | 0.00 | (0.07) | 0.00 | 3.79 | 14.07 | |||
| NYXH | 2.39 | (0.35) | 0.00 | (0.16) | 0.00 | 4.30 | 15.06 |
Cross Equities Net Income Analysis
Compare Journey Medical Corp and related stocks such as OrganiGram Holdings, Cartesian Therapeutics, and China SXT Pharmaceuticals Net Income Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| OGI | (140.2 K) | (140.2 K) | (375.2 K) | (239 K) | (1.3 M) | 846.7 K | (10.9 M) | 20.5 M | (9.5 M) | (136.2 M) | (130.7 M) | (14.3 M) | (229.5 M) | (45.4 M) | (17.8 M) | (16 M) | (16.8 M) |
| RNAC | (12.9 M) | (12.9 M) | (12.9 M) | (12.9 M) | (12.9 M) | (25.2 M) | (36.2 M) | (65.3 M) | (65.3 M) | (55.4 M) | (68.9 M) | (25.7 M) | 35.4 M | (219.7 M) | (77.4 M) | (69.7 M) | (73.2 M) |
| SXTC | 141.5 K | 141.5 K | 141.5 K | 141.5 K | 141.5 K | 141.5 K | 1.2 M | 1.2 M | 1.5 M | (10.3 M) | (2.7 M) | (5.7 M) | (5.9 M) | (3.1 M) | (3.3 M) | (3 M) | (3.1 M) |
| FENC | (1.6 M) | 4.7 M | (5.2 M) | 1.8 M | (2.2 M) | (659 K) | (2.8 M) | (7 M) | (9.9 M) | (12.5 M) | (18.1 M) | (17.2 M) | (22.8 M) | (16 M) | (436 K) | (392.4 K) | (412 K) |
| HSDT | (8.5 M) | (8.5 M) | (8.5 M) | (1.1 M) | (9.8 M) | (6.9 M) | (6.9 M) | (28 M) | (28.6 M) | (9.8 M) | (14.1 M) | (18.1 M) | (14.1 M) | (8.8 M) | (11.7 M) | (10.6 M) | (11.1 M) |
| OBIO | (21.4 M) | (21.4 M) | (21.4 M) | (21.4 M) | (21.4 M) | (21.4 M) | (21.4 M) | (21.4 M) | (21.4 M) | (21.4 M) | (21.4 M) | (23 M) | (33.6 M) | (49.1 M) | (61 M) | (54.9 M) | (57.7 M) |
| IVA | (7.1 M) | (7.1 M) | (7.1 M) | (7.1 M) | (7.5 M) | (8.8 M) | (7 M) | (17.2 M) | (33.6 M) | (30.2 M) | (31.6 M) | (49.6 M) | (54.3 M) | (110.4 M) | (184.2 M) | (165.8 M) | (157.5 M) |
| OSUR | (2.6 M) | (8.8 M) | (15.1 M) | (11.2 M) | (4.6 M) | 8.2 M | 19.7 M | 30.9 M | 20.4 M | 16.7 M | (14.9 M) | (23 M) | (17.1 M) | 53.7 M | (19.5 M) | (22.4 M) | (21.3 M) |
| MDWD | (6.2 M) | (6.2 M) | 10.9 M | (15.4 M) | (18.9 M) | (22.1 M) | (18.9 M) | (22.1 M) | (1.1 M) | 5 M | (9.2 M) | (13.6 M) | (19.6 M) | (6.7 M) | (30.2 M) | (27.2 M) | (25.8 M) |
| NYXH | (10.4 M) | (10.4 M) | (10.4 M) | (10.4 M) | (10.4 M) | (10.4 M) | (10.4 M) | (10.4 M) | (9.1 M) | (9.5 M) | (12.2 M) | (27.6 M) | (31.2 M) | (43.2 M) | (59.2 M) | (53.3 M) | (50.6 M) |
Journey Medical Corp and related stocks such as OrganiGram Holdings, Cartesian Therapeutics, and China SXT Pharmaceuticals Net Income description
Net income is one of the most important fundamental items in finance. It plays a large role in Journey Medical Corp financial statement analysis. It represents the amount of money remaining after all of Journey Medical Corp operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.Journey Medical Competitive Analysis
The better you understand Journey Medical competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Journey Medical's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Journey Medical's competition over several years is one of the best ways to analyze its investment potential.| Better Than Average | Worse Than Peers | View Performance Chart |
Journey Medical Competition Performance Charts
Five steps to successful analysis of Journey Medical Competition
Journey Medical's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Journey Medical Corp in relation to its competition. Journey Medical's competition analysis typically involves several steps, including:- Identifying the key players in the market: This involves identifying the major competitors of Journey Medical in the market, both direct and indirect, as well as new entrants and disruptive technologies.
- Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
- Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Journey Medical's competitive landscape.
- Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Journey Medical Corp, and developing a strategy to address them.
- Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Complement your Journey Medical position
In addition to having Journey Medical in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Robots And Drones Thematic Idea Now
Robots And Drones
Large technology companies that are involved in development and manufacturing of drones, robots, or robotic equipment across mechanical engineering, electrical engineering, mathematics and computer science fields. Drones and robotics are projected to significantly grow in demand in the next 5 years. The Robots And Drones theme has 42 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Robots And Drones Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Journey Medical Correlation with its peers. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Will Biotechnology sector continue expanding? Could Journey diversify its offerings? Factors like these will boost the valuation of Journey Medical. Projected growth potential of Journey fundamentally drives upward valuation adjustments. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Journey Medical data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share (0.35) | Revenue Per Share | Quarterly Revenue Growth 0.205 | Return On Assets | Return On Equity |
Understanding Journey Medical Corp requires distinguishing between market price and book value, where the latter reflects Journey's accounting equity. The concept of intrinsic value - what Journey Medical's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push Journey Medical's price substantially above or below its fundamental value.
It's important to distinguish between Journey Medical's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Journey Medical should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, Journey Medical's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.